Category Filter
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HelpScript Program
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pharmacy
- Pre-Service Review (Precertification and Predetermination)
- Pre-Service Review (Precertification/Predetermination)
- Pre-Service Review (Predetermination/Precertification)
- Provider-Administered Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Asset Publisher
Content with Policies & Guidelines Provider-Administered Drug Claim Edit Policies .
Lupron Depot, Lupron Depot-Ped, Eligard, Fensolvi, Camcevi, Lutrate Depot™, Leuprolide Acetate Depot
print
Print
Bortezomib*
Policy Number: PH-0351
Intravenous Only
Last Review Date: 03/03/2020
Date of Origin: 02/06/2018
Dates Reviewed: 02/2018, 05/2018, 09/2018,...